262 related articles for article (PubMed ID: 7987372)
1. [Arg8]vasotocin excites neurones in the dorsal vagal complex in vitro: evidence for an action through novel class(es) of CNS receptors.
Ingram CD; Tolchard S
J Neuroendocrinol; 1994 Aug; 6(4):415-22. PubMed ID: 7987372
[TBL] [Abstract][Full Text] [Related]
2. Solid-phase synthesis of 16 potent (selective and nonselective) in vivo antagonists of oxytocin.
Manning M; Kruszynski M; Bankowski K; Olma A; Lammek B; Cheng LL; Klis WA; Seto J; Haldar J; Sawyer WH
J Med Chem; 1989 Feb; 32(2):382-91. PubMed ID: 2913298
[TBL] [Abstract][Full Text] [Related]
3. The effects of [Arg8]vasopressin and [Arg8]vasotocin on the firing rate of suprachiasmatic neurons in vitro.
Mihai R; Coculescu M; Wakerley JB; Ingram CD
Neuroscience; 1994 Oct; 62(3):783-92. PubMed ID: 7870306
[TBL] [Abstract][Full Text] [Related]
4. Proconvulsive effect of vasopressin; mediation by a putative V2 receptor subtype in the central nervous system.
Croiset G; De Wied D
Brain Res; 1997 Jun; 759(1):18-23. PubMed ID: 9219858
[TBL] [Abstract][Full Text] [Related]
5. Effects of a D-Cys6/L-Cys6 interchange in nonselective and selective vasopressin and oxytocin antagonists.
Manning M; Cheng LL; Klis WA; Balaspiri L; Olma A; Sawyer WH; Wo NC; Chan WY
J Med Chem; 1995 May; 38(10):1762-9. PubMed ID: 7752199
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of V1a vasopressin receptors in the rat cortical collecting duct.
Ammar A; Roseau S; Butlen D
Am J Physiol; 1992 Apr; 262(4 Pt 2):F546-53. PubMed ID: 1533099
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of the biological effects of neurohypophysial peptides on seminiferous tubules.
Harris GC; Nicholson HD
J Endocrinol; 1998 Jan; 156(1):35-42. PubMed ID: 9496231
[TBL] [Abstract][Full Text] [Related]
8. Design of oxytocin antagonists, which are more selective than atosiban.
Manning M; Stoev S; Cheng LL; Wo NC; Chan WY
J Pept Sci; 2001 Sep; 7(9):449-65. PubMed ID: 11587184
[TBL] [Abstract][Full Text] [Related]
9. A V1-type receptor for mediating the neurohypophysial hormone-induced ACTH release in trout pituitary.
Pierson PM; Guibbolini ME; Lahlou B
J Endocrinol; 1996 Apr; 149(1):109-15. PubMed ID: 8676042
[TBL] [Abstract][Full Text] [Related]
10. Oxytocin antagonist blocks the vasodepressor but not the vasopressor effect of neurohypophysial peptides in chickens.
Robinzon B; Koike TI; Marks PA
Peptides; 1994; 15(8):1407-13. PubMed ID: 7700844
[TBL] [Abstract][Full Text] [Related]
11. V2-like vasopressin receptor mobilizes intracellular Ca2+ in rat medullary collecting tubules.
Champigneulle A; Siga E; Vassent G; Imbert-Teboul M
Am J Physiol; 1993 Jul; 265(1 Pt 2):F35-45. PubMed ID: 8342613
[TBL] [Abstract][Full Text] [Related]
12. Frog glomerular vasotocin receptors resemble mammalian V1b receptors.
Ammar A; Rajerison RM; Roseau S; Bloch-Faure M; Butlen D
Am J Physiol; 1994 Nov; 267(5 Pt 2):R1198-208. PubMed ID: 7977846
[TBL] [Abstract][Full Text] [Related]
13. Effects of vasopressin and angiotensin II on neurones in the rat dorsal motor nucleus of the vagus, in vitro.
Mo ZL; Katafuchi T; Muratani H; Hori T
J Physiol; 1992 Dec; 458():561-77. PubMed ID: 1302279
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of vasotocin stimulation of phosphoinositide turnover in frog adrenal gland.
Larcher A; Delarue C; Homo-Delarche F; Kikuyama S; Kupryszewski G; Vaudry H
Endocrinology; 1992 Jan; 130(1):475-83. PubMed ID: 1309345
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of arginine vasotocin vascular smooth muscle receptors in the trout (Oncorhynchus mykiss) in vitro.
Conklin DJ; Smith MP; Olson KR
Gen Comp Endocrinol; 1999 Apr; 114(1):36-46. PubMed ID: 10094857
[TBL] [Abstract][Full Text] [Related]
16. Neurohypophyseal hormones manipulation modulate social and anxiety-related behavior in zebrafish.
Braida D; Donzelli A; Martucci R; Capurro V; Busnelli M; Chini B; Sala M
Psychopharmacology (Berl); 2012 Mar; 220(2):319-30. PubMed ID: 21956239
[TBL] [Abstract][Full Text] [Related]
17. Vasopressin and oxytocin receptors on plasma membranes from rat mammary gland. Demonstration of vasopressin receptors by stimulation of inositol phosphate formation, and oxytocin receptors by binding of a specific 125I-labeled oxytocin antagonist, d(CH2)5(1)[Tyr(Me)2, Thr4,Tyr-NH2(9)]OVT.
Soloff MS; Fernström MA; Fernström MJ
Biochem Cell Biol; 1989; 67(2-3):152-62. PubMed ID: 2546575
[TBL] [Abstract][Full Text] [Related]
18. Effect of AVP and oxytocin on insulin release: involvement of V1b receptors.
Lee B; Yang C; Chen TH; al-Azawi N; Hsu WH
Am J Physiol; 1995 Dec; 269(6 Pt 1):E1095-100. PubMed ID: 8572202
[TBL] [Abstract][Full Text] [Related]
19. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
[TBL] [Abstract][Full Text] [Related]
20. Discovery of novel selective hypotensive vasopressin peptides that exhibit little or no functional interactions with known oxytocin/vasopressin receptors.
Chan WY; Wo NC; Stoev S; Cheng LL; Manning M
Br J Pharmacol; 1998 Oct; 125(4):803-11. PubMed ID: 9831918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
